China Pharma Holding (STU:XQJ) Tariff Resilience Score: 4/10 (As of Jul. 11, 2026)


STU:XQJ China Pharma Holding Inc STU:XQJ
26 GF Score
Price €26.80
GF Value €11.28
! 3 Warning Signs
View Full Analysis

What is China Pharma Holding Tariff Resilience Score?

China Pharma Holding STU:XQJ 26 Tariff Resilience Score is 4 as of Jul. 11, 2026. GuruFocus rates STU:XQJ with a GF Score™ of 26/100 and a GF Value™ of €11.28. The stock has 3 warning signs investors should review. Among 1,029 Drug Manufacturers companies, China Pharma Holding ranks better than 79.69% on this metric.

China Pharma Holding has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

China Pharma Holding has Significant exposure to U.S.-China trade tensions. Manufacturing in China with exports to the U.S. makes it vulnerable. Limited pricing power and historical tariff impacts have been negative.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes China Pharma Holding might have Average Resilient.

China Pharma Holding  (STU:XQJ) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

China Pharma Holding Tariff Resilience Score Related Terms

STU:XQJ vs TXMD, RMTI, AYTU: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Pharma Holding Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where China Pharma Holding's Tariff Resilience Score falls into.


STU:XQJ
26GF Score
China Pharma Holding Inc STU:XQJ
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
China Pharma Holding (STU:XQJ) has a Tariff Resilience Score of 4 as of Jul. 11, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, China Pharma Holding ranks #209 out of 1029 companies in the Drug Manufacturers industry, placing it in the top 20.3%.
Is China Pharma Holding's Tariff Resilience Score too high?
China Pharma Holding's current Tariff Resilience Score is 4. Based on the distribution chart, China Pharma Holding ranks #209 out of 1029 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Pharma Holding has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does China Pharma Holding's Tariff Resilience Score compare to TXMD and RMTI?
According to the Drug Manufacturers industry distribution chart, China Pharma Holding ranks #209 out of 1029 companies for Tariff Resilience Score. This places China Pharma Holding in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. China Pharma Holding's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Pharma Holding stock overvalued right now?
China Pharma Holding (STU:XQJ) has a current Tariff Resilience Score of 4. The stock's GF Value™ is €11.28, compared to a current price of €26.80 — trading 137.6% above its estimated fair value. The current Tariff Resilience Score is 4. China Pharma Holding's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For China Pharma Holding (STU:XQJ), the current Tariff Resilience Score is 4 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Pharma Holding (STU:XQJ) Overvalued in 2026?

Based on GuruFocus' analysis, China Pharma Holding stock appears to be overvalued. The current stock price of €26.80 is trading 137.6% above its estimated GF Value™ of €11.28.

Key valuation signals for STU:XQJ:

  • Tariff Resilience Score: 4
  • GF Value™: €11.28 vs. price of €26.80 (137.6% above fair value)
  • GF Score™: 26/100 with 3 warning signs

No single metric tells the full story. See the STU:XQJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Pharma Holding Business Description

Other Exchanges CPHI:USA
Address No. 17, Jinpan Road, Second Floor, Jiahai Building, Hainan Province, Haikou, CHN, 570216
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
26GF Score

Get the complete analysis for STU:XQJ

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€26.80
Price
€11.28
GF Value